医学部・外科学

Medicine and Dentistry

1. Hepatectomy 100%
2. Liver Cirrhosis 45%
3. Portal Hypertension 44%
4. Rectum Cancer 41%
5. Chemoradiotherapy 41%
6. Cancer 41%
7. Recurrent Disease 39%
8. Neoplasm 38%
9. Surgery 32%
10. Body Mass Index 30%
11. Gastrointestinal Stromal Tumor 27%
12. Imatinib 27%
13. Propensity Score Matching 19%
14. Bleeding 19%
15. Liver Surgery 19%
16. Retrospective Study 15%
17. Hepatocellular Carcinoma 13%
18. Gastrectomy 13%
19. Colorectal Cancer 13%
20. Metastatic Carcinoma 13%
21. Colorectal Liver Metastasis 13%
22. Lymph Node 13%
23. Cancer Surgery 13%
24. Squamous Cell Carcinoma 13%
25. Abdominal Cancer 13%
26. Neoadjuvant Chemotherapy 13%
27. Monotherapy 13%
28. Neoadjuvant Therapy 13%
29. Nivolumab 13%
30. Lymphocyte 13%
31. Conversion Therapy 13%
32. Kocher Manoeuvre 13%
33. Colorectal Carcinoma 13%
34. Blood Transfusion 13%
35. Lymph Node Metastasis 11%
36. Preoperative Chemotherapy 10%
37. Operation Duration 9%
38. Robot-Assisted Surgery 9%
39. Radiation Therapy 9%
40. Fluorouracil 9%
41. Underweight 7%
42. Platelet 6%
43. Neutrophil 6%
44. Morbidity 5%
45. Liver Function 5%
46. Pringle Manoeuvre 5%
47. Pelvis Abscess 5%
48. Mitomycin 5%

Keyphrases

1. Curative Surgery 28%
2. Chemoradiotherapy 27%
3. Anal Squamous Cell Carcinoma 27%
4. R0 Resection 27%
5. Colorectal Cancer 27%
6. Postoperative Outcomes 22%
7. Treatment Outcome 20%
8. Liver Resection 15%
9. Retrospective Analysis 15%
10. Cirrhosis 14%
11. Laparoscopic Hepatectomy 13%
12. Adjacent Organ 13%
13. Concurrent Chemoradiotherapy 13%
14. Minimally Invasive 13%
15. International multicenter Study 13%
16. Propensity Score Analysis 13%
17. Left Lateral Sectionectomy 13%
18. Case Series Report 13%
19. Anterolateral Segments 13%
20. Body Mass Index 13%
21. Low Rectal Cancer 13%
22. Portal Hypertension 13%
23. Neoadjuvant Therapy 13%
24. Liver Cirrhosis 13%
25. Stage IV Colorectal Cancer 13%
26. Skip Metastasis 13%
27. Clinical Outcomes 13%
28. Lateral Lymph Node Metastasis 13%
29. Robotics 13%
30. Effectiveness Mechanism 13%
31. Motion Mechanism 13%
32. TJ-100 13%
33. Postoperative Follow-up 13%
34. Multi-institutional 13%
35. R0 Surgery 13%
36. Duodenal Gastrointestinal Stromal Tumors 13%
37. Global Outcome 13%
38. Liver Malignancy 13%
39. Rectal Carcinoma 13%
40. Preoperative Chemotherapy 13%
41. Neoadjuvant Chemoradiotherapy (nCRT) 13%
42. Conversion Therapy 13%
43. Kocher Maneuver 13%
44. Local Gastrectomy 13%
45. Robot-assisted Surgery 13%
46. CRP to Albumin Ratio 12%
47. Perianal Lesion 10%
48. Superior Rectal Artery 9%
49. Robotic Surgery 9%
50. Blood Loss 8%
51. Complete Response 8%
52. Radiotherapy 7%
53. 5-fluorouracil (5-FU) 7%
54. Anal Function 6%
55. Urinary Function 6%
56. Recurrent Disease 6%
57. Child-Pugh A 6%
58. Length of Hospital Stay 6%
59. Tumor 5%
60. Mitomycin C 5%
61. Major Morbidity 5%
62. Clinical Records 5%